JASON ARNETT: Open Payments
NPI 1336132034 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,306 in 128 payments from 24 companies in 2025. Trend: 2023 $2,491 · 2024 $2,252 · 2025 $2,306
Food & beverage: $2,306
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $344 |
| UCB, Inc. | 17 | $341 |
| ABBVIE INC. | 20 | $250 |
| Janssen Biotech, Inc. | 15 | $174 |
| PFIZER INC. | 8 | $159 |
| Novartis Pharmaceuticals Corporation | 7 | $157 |
| GENZYME CORPORATION | 4 | $124 |
| Organon LLC | 10 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| LEO Pharma Inc. | 3 | $69 |
Products named: Bimzelx, ILUMYA, TREMFYA, DUPIXENT, SKYRIZI, CIBINQO, COSENTYX, RINVOQ.
Industry payments across AZ — which companies pay providers there.
